[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Glaukos Corporation Graphic Glaukos Corporation (GKOS)

Glaukos Corporation ($GKOS) sees new alerts posted, but the stock is also mentioned in broader discussions of market losers. Recent price drops and market concerns suggest caution, despite some positive sentiment from alerts and discussions of long-term positions.

About Glaukos Corporation

Glaukos Corporation (GKOS) is a healthcare company.
Glaukos Corporation uses the ticker $GKOS for trading. Listed in the Stocks and category within the Healthcare sectors.

Insights #

Price: $XXXXX #


Price Line Chart
Price 24-Hour Time-Series Raw Data
The price is currently at $82.40, with a 24-hour increase of XXXX% but a 7-day decrease of -10.37%. The recent price drops and broader market discussions suggest caution, despite some positive sentiment from alerts and discussions of long-term positions.

24-Hour 7-Day 30-Day
XXXX% -XXXX% XXXX%

1-Year High: $XXXXXX on 2025-01-23
1-Year Low: $XXXXX on 2025-09-26

AltRank: XXXXX #


AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Glaukos Corporation (GKOS) is currently AltRank #2,138 based on combined combined social and market metrics Daily Average: XXXXX
1 Week: XXXXX -XX
1 Month: XXXXX +70
6 Months: XXXXX +1,442
1 Year: XXXXX +814
1-Year High: XXXXX on 2025-09-13
1-Year Low: XX on 2024-12-29

Galaxy Score: XXXXX #


Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -X
1 Month: XX -X
6 Months: XX -XX
1 Year: XX +12
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2024-10-31

Engagements: XXX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXXXX -XX%
1 Month: XXXXXX +73%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-02-21
1-Year Low: XX on 2025-03-30

Social Network X
Engagements XXX

Mentions: XX #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
6 Months: XXX -XX%
1 Year: XXXXX +9.20%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-19

Social Network X
Mentions XX

Creators: XX #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Glaukos Corporation (GKOS) in the last XX hours which is up XXX% from X in the previous XX hours Daily Average: XX
6 Months: XXX +79%
1 Year: XXXXX +113%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-03-30

The most influential creators that mention Glaukos Corporation in the last XX hours

Creator Rank Followers Posts Engagements
@MarcJacksonLA X XXXXX X XX

View More

Sentiment: XX% #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XX% +40%
6 Months: XX% -XX%
1 Year: XX% +16%
1-Year High: XXX% on 2025-01-11
1-Year Low: X% on 2025-09-27

Most Supportive Themes

Most Critical Themes

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXX XX% XXX XX% XX X%
Total XXX XX% XXX XX% XX X%

Social Dominance: XXXXXXX% #


Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
1 Week: XXXXXX% +0.0011%
1 Month: XXXXXX% no change
6 Months: XXXXXX% -XXXXXX%
1 Year: XXXXXX% -XXXXXX%
1-Year High: XXXXX% on 2024-11-01
1-Year Low: XXXXXX% on 2025-09-19

Market Dominance: XXXXXXX% #


Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-11-06
1-Year Low: XXXXXXX% on 2025-10-15

Market Cap: $XXXXXXXXXXXXX #


Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX -$2.30%
1 Month: $XXXXXXXXXXXXX +$6.20%
6 Months: $XXXXXXXXXXXXX -$4.70%
1 Year: $XXXXXXXXXXXXX -$30%
1-Year High: $XXXXXXXXXXXXX on 2025-01-23
1-Year Low: $XXXXXXXXXXXXX on 2025-09-26

Top assets mentioned In the posts about Glaukos Corporation in the last XX hours

Amgen, Inc. (AMGN) Guardant Health, Inc. Common Stock (GH) TransMedics Group, Inc. Common Stock (TMDX) BioMarin Pharmaceutical, Inc. (BMRN) Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Apogee Therapeutics, Inc. Common Stock (APGE) Jazz Pharmaceuticals, Inc. (JAZZ) Merck & Co., Inc. (MRK) Helium IOT (IOT)

Top topics mentioned In the posts about Glaukos Corporation in the last XX hours

stocks healthcare, longterm, $arqt, coins defi, $amgn, stocks technology, stocks industrials, $gh, stocks financial services, $voo, $qqq, $tmdx, promising, $bmrn, $amrx, $apge, $jazz, $mrk, coins solana ecosystem, coins depin, $iot, $197m, $1241m, $480m, $486m, alexis, $wyfi, stocks real estate, $aapl, investment, ira, gsk plc, $967k, $93k, $946k, $21k, $10550m, $3358m, $ghrs, general motors, stocks consumer cyclical, $glbe, $gfr, $wfc, $1511k, $908k, $1244k, $266k, $hca, $exas, $gev, $hsbc

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$GHRS -Needham initiates GH Research coverage at Buy $XX target - $GKOS -BTIG lowers Glaukos target to $XXX from $XXX Buy - $GLBE -Goldman Sachs raises Global-e target to $XX from $XX Buy - $GM -Evercore raises General Motors target to $XX from $XX Outperform -"
X Link @MarcJacksonLA 2025-10-13T19:38Z 7570 followers, XXX engagements

"Upcoming PDUFA dates for October 2025: October XX $ARQT October XX $AMGN October XX $GKOS October XX $GSK October XX $MRK $SNDX #FDAApprovals #BiotechStocks #PDUFA"
X Link @fastmoneysource 2025-10-11T13:53Z XX followers, XXX engagements

"I added some $GKOS yesterday in my IRA. not investment advice"
X Link @TaoistTrader 2025-10-09T13:17Z XXX followers, XX engagements

"👁 $GKOS Big move coming in keratoconus: Glaukos' Epioxa (Epi-on) hits 2/2 wins in Phase X showing significant Kmax improvement at XX months vs. sham. Non-invasive epi-on design + strong safety = game-changer. NDA by end of 2024. Est. XX% FDA approval chance. #ophthalmology"
X Link @Big_Ballski 2025-10-08T23:52Z XXX followers, XX engagements